Adam S. Grossman - Jun 14, 2024 Form 4 Insider Report for ADMA BIOLOGICS, INC. (ADMA)

Signature
/s/ Adam S. Grossman, by Michael A. Goldstein as Attorney-in-fact
Stock symbol
ADMA
Transactions as of
Jun 14, 2024
Transactions value $
-$2,548,580
Form type
4
Date filed
6/14/2024, 09:00 PM
Previous filing
Apr 2, 2024
Next filing
Jul 2, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADMA Common Stock Other -$1.48M -460K -17.35% $3.21 2.19M Jun 14, 2024 Direct F1, F2, F3, F4, F5
transaction ADMA Common Stock Gift $0 -10K -0.46% $0.00 2.18M Jun 14, 2024 Direct F3, F4, F5, F6
transaction ADMA Common Stock Sale -$1.07M -100K -4.58% $10.72 2.08M Jun 14, 2024 Direct F3, F4, F5, F7
holding ADMA Common Stock 1.14M Jun 14, 2024 See Footnote F8
holding ADMA Common Stock 581K Jun 14, 2024 See Footnote F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were transferred by the reporting person in accordance with the terms of a court-approved divorce settlement agreement (the "Divorce Settlement").
F2 The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 Includes, as of the transaction date, (i) 557,728 RSUs granted on February 26, 2024, vesting quarterly on each annual anniversary of the date of grant over four years, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting; (ii) 430,272 unvested RSUs granted on March 6, 2023 that will vest quarterly on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting; (iii) 150,000 unvested RSUs granted on March 7, 2022 that will vest quarterly on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date and that will be settled into common stock upon vesting;
F4 (continued from footnote 3) (iv) 170,157 unvested Time-Based RSUs granted on September 29, 2021, subject to time-based vesting conditions (the "Time-Based RSUs") which will vest in eight (8) equal quarterly installments over a period of two years following December 31, 2022, becoming fully vested on December 31, 2024 and that will be settled into common stock upon vesting, subject to the reporting person's continued employment on the applicable vesting date; (v) 45,785 unvested RSUs granted on February 25, 2021, which will vest in equal quarterly installments on each annual anniversary of the date of grant, over four years, subject to the reporting person's continued service as of the applicable vesting date, will be settled into common stock upon vesting;
F5 (continued from footnote 4) and (vi) 727,533 shares of common stock owned by the reporting person, which reflects prior purchases and the prior net settlement upon vesting of previously granted RSUs after the withholding of shares to cover applicable taxes.
F6 The shares were transferred by the reporting person to a third party in connection with the Divorce Settlement.
F7 These shares were sold by the reporting person in connection with the Divorce Settlement.
F8 These shares are owned by Areth, LLC ("Areth"). The reporting person is a control person of Areth.
F9 These shares are owned by Hariden, LLC ("Hariden"). The reporting person is the managing member of Hariden.